Antiviral activity of triptolide on herpes simplex virus in vitro

BACKGROUND: Herpes simplex virus‐type 1 (HSV‐1) can cause diseases, especially amongst neonates and immunocompromised hosts. Hence, developing a novel anti‐HSV‐1 drug with low‐level toxicity is vital. Triptolide (TP), a diterpenoid triepoxide is a natural product with range of bioactivity qualities....

Descripción completa

Detalles Bibliográficos
Autores principales: Aliabadi, Nasrin, Jamalidoust, Marzieh, Pouladfar, Gholamreza, Ziyaeyan, Atoosa, Ziyaeyan, Mazyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208287/
https://www.ncbi.nlm.nih.gov/pubmed/35759241
http://dx.doi.org/10.1002/iid3.667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208287/
https://www.ncbi.nlm.nih.gov/pubmed/35759241
http://dx.doi.org/10.1002/iid3.667

Ejemplares similares